๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension

โœ Scribed by Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
126 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Patients with Parkinson's disease (PD) often have manifestations of autonomic failure. About 40% have neurogenic orthostatic hypotension (NOH), and among PD+NOH patients virtually all have evidence of cardiac sympathetic denervation; however, whether PD+NOH entails extraโ€cardiac noradrenergic denervation has been less clear. Microdialysate concentrations of the main neuronal metabolite of norepinephrine (NE) and dihydroxyphenylglycol (DHPG) were measured in skeletal muscle, and plasma concentrations of NE and DHPG were measured in response to i.v. tyramine, yohimbine, and isoproterenol, in patients with PD+NOH, patients with pure autonomic failure (PAF), which is characterized by generalized catecholaminergic denervation, and control subjects. Microdialysate DHPG concentrations were similarly low in PD+NOH and PAF compared to control subjects (163 ยฑ 25, 153 ยฑ 27, and 304 ยฑ 27 pg/mL, P < 0.01 each vs. control). The two groups also had similarly small plasma DHPG responses to tyramine (71 ยฑ 58 and 82 ยฑ 105 vs. 313 ยฑ 94 pg/mL; P < 0.01 each vs. control) and NE responses to yohimbine (223 ยฑ 37 and 61 ยฑ 15 vs. 672 ยฑ 130 pg/mL, P < 0.01 each vs. control), and virtually absent NE responses to isoproterenol (20 ยฑ 34 and 14 ยฑ 15 vs. 336 ยฑ 78 pg/mL, P < 0.01 each vs. control). Patients with PD+NOH had normal bradycardia responses to edrophonium and normal epinephrine responses to glucagon. The results support the concept of generalized noradrenergic denervation in PD+NOH, with similar severity to that seen in PAF. In contrast, the parasympathetic cholinergic and adrenomedullary hormonal components of the autonomic nervous system seem intact in PD+NOH. ยฉ 2008 Movement Disorder Society


๐Ÿ“œ SIMILAR VOLUMES


Orthostatic hypotension, balance and fal
โœ Maarit Matinolli; Juha T. Korpelainen; Raija Korpelainen; Kyรถsti A. Sotaniemi; V ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB ๐Ÿ‘ 1 views

## Abstract Orthostatic hypotension (OH) is a common feature in Parkinson's disease (PD). As the control of balance and gait is already affected by PD per se, OH may further predispose patients to falls and accidents. The study was conducted to evaluate the clinical correlates of OH and its associa

Orthostatic hypotension in Parkinson's d
โœ Liesl M. Allcock; Rose Anne Kenny; Urs Peter Mosimann; Sherley Tordoff; Keith A. ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB

## Abstract ## Background Orthostatic hypotension is common in Lewy body disorders and may be related to disease progression and the spread of Lewy body pathology. We therefore hypothesize that PD patients with orthostatic hypotension (OH) have a different cognitive profile compared to PD patients

Nonpharmacological treatment, fludrocort
โœ Kerrie L. Schoffer; Robert D. Henderson; Karen O'Maley; John D. O'Sullivan ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB

## Abstract There is limited evidence for the treatment of orthostatic hypotension in idiopathic Parkinson's disease. The objective of this study was to determine the efficacy of three treatments (nonpharmacological therapy, fludrocortisone, and domperidone). Phase I assessed the compliance, safety

Clinical phenotype of subjects with Park
โœ Liesl M. Allcock; Rose Anne Kenny; David J. Burn ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 57 KB

## Abstract The objective of this study was to characterize the phenotypic associations of orthostatic hypotension (OH) in Parkinson's disease (PD). One hundred fiftyโ€nine subjects with PD underwent assessment including autonomic symptom severity scoring, diseaseโ€specific rating scales, and measure

Cholinergic and other neurotransmitter m
โœ Paul T. Francis; Elaine K. Perry ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b